Texas Southern University Appoints Highly Experienced Academician as Next Provost

Dr. Carl Goodman is a Distinguished Scholar Committed to Academic Excellence and Student Success

Style Magazine Newswire | 4/26/2023, 3:45 p.m.
A seasoned higher education administrator and effective champion of faculty and student success will become the new provost and senior …
Dr. Carl Goodman

A seasoned higher education administrator and effective champion of faculty and student success will become the new provost and senior vice president for academic affairs at Texas Southern University.

Dr. Carl Goodman will arrive at TSU on July 1, 2023, as the chief academic officer responsible for advancing the academic enterprise of the university. He will join TSU from Bowie State University (BSU), where, for the past three years, he served as provost and senior vice president for academic affairs. As chief academic officer, Dr. Goodman was responsible for leading academic growth and research innovation.

“At Texas Southern University, we value knowledge and experience and Dr. Carl Goodman embodies both” said President Dr. Lesia L. Crumpton-Young. “He has demonstrated a commitment to teaching, research and innovation as well as student success throughout his career. We look forward to him contributing to our mission of transforming lives and providing exceptional leadership at our esteemed university.”

Prior to joining BSU, Dr. Goodman was with Florida A&M University (FAMU), where he served as associate provost for academic affairs and student services. He was responsible for assuring the quality of academic programs and curricula reviews, self-study reports and specialized accreditation activities of the 13 colleges and schools. An effective champion of student success, during his tenure at FAMU, Dr. Goodman made remarkable achievements with enhancing the undergraduate education and student success areas, improving the university’s six-year graduation rate by nearly 15 percent in four years, retention rates and the reduction of excess credit hours. He accomplished those outcomes by implementing the FAMU’s first Early Alert System and a Finish in Four Program to improve the four-year graduation rates.

He has enjoyed more nearly 30 years of a distinguished career in teaching, research and service in FAMU’s flagship program, the College of Pharmacy and Pharmaceutical Sciences, recognized as a top five pharmacy program in generating U.S. patents. As assistant dean for research and graduate studies and as the pharmaceutical sciences division director, he restructured a vibrant graduate program through faculty development, key hires and student recruitment. He also developed a new Bachelor of Science program in the pharmaceutical sciences in the college. Dr. Goodman has a strong track record in securing grants, with more than $39 million in research and student training grants awarded to strengthen FAMU’s research capacity and infrastructure.

Additionally, Dr. Goodman has extensive experience as a researcher on grant-funded programs and is passionate about providing research opportunities for undergraduates, graduate students and faculty. As co-principal investigator for the FAMU Research Centers in Minority Institutions Program, he directed a $14.8 million grant from the National Institutes of Health (NIH) and the National Institution for Minority Health and Health Disparity. He has co-authored or authored more than 39 peer-reviewed articles. His research interests include the molecular and cellular basis of opioid tolerance and addiction.

“I am truly delighted to become a part of Texas Southern University with its outstanding faculty, innovative research initiatives, and exceptional students,” said Dr. Goodman. “My vision is to create a learning-centered environment where students are receiving exceptional educational experiences from extraordinary faculty.”

Dr. Goodman holds a doctoral degree in pharmacology/toxicology from Florida A&M University and a bachelor’s degree in biology and psychology from Jacksonville University. He was a postdoctoral NIH fellow at the National Institute of Drug Abuse.